InvestorsObserver
×
News Home

Should You Buy Evofem Biosciences Inc (EVFM) Stock on Tuesday?

Tuesday, October 12, 2021 10:03 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Evofem Biosciences Inc (EVFM) Stock on Tuesday?

Evofem Biosciences Inc (EVFM) stock is unchanged 0.00% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Evofem Biosciences Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on EVFM!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With EVFM Stock Today?

Evofem Biosciences Inc (EVFM) stock is lower by -3.09% while the S&P 500 has gained 0.06% as of 9:52 AM on Tuesday, Oct 12. EVFM is down -$0.02 from the previous closing price of $0.76 on volume of 462,286 shares. Over the past year the S&P 500 has gained 23.47% while EVFM is down -74.57%. EVFM lost -$1.70 per share in the over the last 12 months. To screen for more stocks like Evofem Biosciences Inc click here.

More About Evofem Biosciences Inc

Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women. Click Here to get the full Stock Report for Evofem Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App